In correspondence on a study protocol published in #BMCNeurol (https://t.co/N9w2ztvo0E), Coste & Touitou questioned whether hypoxia treatment of Parkinson’s disease may disrupt the circadian system (https://t.co/a9y0Mvp4BH) - Daalen et al think not: ht
Study rationale and protocol for the Talisman study. Proof of concept test of N-of-1 design could be way forward for assessing personalised treatment approaches. Looking forward to seeing the results! https://t.co/7qzsVAyO87
Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson's disease: study rationale and protocol. https://t.co/o7LN8tTtUF https://t.co/pWehU3Cm1Z
RT @ScienceofPD: The study rationale & protocol for multiple N-of-1 trials to investigate hypoxia therapy in #Parkinsons - from @basbloem &…